SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

Community members are rallying around the belief that DOG acts as a Bitcoin-native memecoin that will eventually outperform traditional alternatives through its decentralized structure and fixed supply. Despite ongoing market volatility and skepticism from critics, proponents are focused on long-term accumulation and the potential for a significant price breakout during the next market cycle.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing high market volatility as traders debate the sustainability of its AI-driven optical infrastructure thesis amid ongoing capacity expansion and concerns over lofty valuation multiples. The stock remains a focal point for high-beta investors, with heavy call flow positioning for long-term photonics demand despite recurring institutional insider selling and short-term price swings.

The Cosmos network consists of many independent, parallel blockchains, called zones, each powered by classical Byzantine fault-tolerant (BFT) consensus protocols like Tendermint. Some zones act as hubs with respect to other zones, allowing many zones to interoperate through a shared hub. The architecture uses classic BFT and Proof-of-Stake algorithms, instead of Proof-of-Work. Cosmos can interoperate with multiple other applications and cryptocurrencies, something other blockchains can’t do well. By creating a new zone, you can plug any blockchain system into the Cosmos hub and pass tokens back and forth between those zones, without the need for an intermediary.  While the Cosmos Hub is a multi-asset distributed ledger, there is a special native token called the atom. ATOM have three use cases: as a spam-prevention mechanism, as staking tokens, and as a voting mechanism in governance.  As a spam prevention mechanism, ATOM are used to pay fees. The fee may be proportional to the amount of computation required by the transaction, similar to Ethereum’s concept of “gas”. Fee distribution is done in-protocol and a protocol specification is described here.  As staking tokens, ATOM can be “bonded” in order to earn block rewards. The economic security of the Cosmos Hub is a function of the amount of ATOM staked. The more ATOM that are collateralized, the more “skin” there is at stake and the higher the cost of attacking the network. Thus, the more ATOM there are bonded, the greater the economic security of the network.  Atom holders may govern the Cosmos Hub by voting on proposals with their staked ATOM.

Cosmos

Cosmos is generating buzz as investors focus on its high staking yields and potential for long-term growth, with the community actively discussing future catalysts like the Clarity Act. Many are using the current market phase to accumulate and stake ATOM while debating whether the project's utility and ecosystem developments can spark a significant breakout.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor (TAO) is trending as investors rotate toward decentralized, censorship-resistant AI networks following reports that major centralized AI models are being restricted over national security concerns. The community is actively discussing the protocol's long-term utility and staking rewards, while many see it as a structural alternative to the potential limitations of centralized Big Tech AI.

WorldFinancial

WLFI is currently the subject of intense community debate and volatility, driven by a controversial governance vote aimed at locking up tokens and high-profile legal conflict involving major investors. While some participants anticipate a potential supply shock and future recovery, others are actively warning of a systematic scam and long-term decline.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is gaining momentum as investors track technical breakout patterns and speculate on ecosystem expansion driven by the project's push into IoT and data ownership infrastructure. Community discussions are centered on renewed trading volume and the potential for the asset to capitalize on broader market rotations into Japanese blockchain projects.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) remains a focal point for the retail trading community as traders analyze the stocks potential for a repeat short squeeze, drawing frequent comparisons to its historic volatility and the influence of institutional share locking. While some market participants speculate on another parabolic surge driven by high short interest and tight float dynamics, others emphasize the company's significant debt load and weak fundamentals, creating a highly polarized debate between those betting on technical squeeze mechanics and those anticipating a return to long-term valuation levels.

TOSHI

TOSHI is trending as investors aggressively accumulate in anticipation of potential utility-driven catalysts and a rotation of capital into the Base ecosystem. The community remains highly bullish, citing rumors of upcoming AI partnerships and exchange listings as key drivers for a potential breakout from current consolidation levels.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is currently the focus of investor excitement as the company reported positive Phase 1 clinical data for subcutaneous Briumvi, fueling community speculation about a potential buyout and long-term valuation growth. While some investors are concerned by volatility and the pace of price action, others are actively discussing the stock's potential for significant upside as it expands its therapeutic reach beyond multiple sclerosis.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft.The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is dominating market conversation following its historic IPO, with the community actively debating whether the company's multi-trillion-dollar valuation is justified by its long-term vision for space infrastructure, AI, and multiplanetary travel. Opinions remain sharply divided between those calling it an overvalued, loss-making asset primed for a correction and long-term believers who view it as the foundational platform for the next century of technological innovation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Definium Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that members of the Companys management team will participate in a...

Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder

Definium Therapeutics, Inc. (Nasdaq: DFTX) (Definium or the Company), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address the underlying...

Definium Therapeutics Announces New Employee Inducement Grants

Definium Therapeutics, Inc. (Definium or the Company), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric...

Definium Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights

Definium Therapeutics, Inc. (Definium or the Company) (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes...

Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026

Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that it will host a live webcast at 4:30 p.m. EDT on Thursday, May...

Definium Therapeutics, Inc. (NASDAQ:DFTX) Receives Consensus Recommendation of "Buy" from Analysts

Shares of Definium Therapeutics, Inc. (NASDAQ:DFTX - Get Free Report) have been given a consensus rating of "Buy" by the fifteen brokerages that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, eleven have given a buy recom...

Definium Therapeutics, Inc. (NASDAQ:DFTX) Short Interest Update

Definium Therapeutics, Inc. (NASDAQ:DFTX - Get Free Report) was the target of a large decline in short interest during the month of April. As of April 15th, there was short interest totaling 9,819,886 shares, a decline of 35.1% from the March 31st total of 15,129,638 shares. Currently, 10.1% of...

Definium Therapeutics (NASDAQ:DFTX) Stock Price Down 6.7%  - Here's What Happened

Definium Therapeutics (NASDAQ:DFTX) Shares Down 6.7% - Here's What Happened...

Q1 Earnings Estimate for DFTX Issued By HC Wainwright

Definium Therapeutics, Inc. (NASDAQ:DFTX - Free Report) - Investment analysts at HC Wainwright issued their Q1 2027 earnings estimates for shares of Definium Therapeutics in a report issued on...

Definium Therapeutics Investor Day: DT120 Phase III Readouts Set for Late Q2-Q3, PTSD Plan for 2027

Definium Therapeutics (NASDAQ:DFTX) used a company event to outline its late-stage development plans for DT120, an oral disintegrating tablet (ODT) formulation of LSD being studied for generalized anxiety disorder (GAD) and major depressive disorder (MDD), with an additional phase III study in post...

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Current Price	$24.75
Prev Close	$24.11
Open	$24.32
Dividend Yield	0.00%
50-Day Moving Average	$22.33
Beta	1.76
Avg. Volume	1.6M
PE Ratio	-9.89

52-Week High	$26.25
52-Week Low	$6.35
Market Capitalization	$2.7B
EPS (Annual)	-$2.06
Price to Book	9.23
Revenue Per Employee	$0.00

DFTXDefinium Therapeutics Inc.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DFTX News